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Abstract
The SWI/SNF chromatin remodeling complex is an essential regulator of transcription of cellular
genes. HIV-1 infection induces exit of a core component of SWI/SNF, Ini1, into the cytoplasm and
its association with the viral pre-integration complex. Several recent papers published in EMBO
Journal, Journal of Biological Chemistry, and Retrovirology provide new information regarding
possible functions of Ini1 and SWI/SNF in HIV life cycle. It appears that Ini1 has an inhibitory effect
on pre-integration steps of HIV replication, but also contributes to stimulation of Tat-mediated
transcription. This stimulation involves displacement of the nucleosome positioned at the HIV
promoter.
Transcription of integrated HIV genome, as well as other
genes, has to deal with nucleosomes that cover DNA and
limit its access to transcription machinery. Interestingly,
regardless of the integration site, nucleosomes are found
at specific positions within the HIV LTR [1]. Transcription
is initiated within the nucleosome-free region between
nuc-0 and nuc-1, and leads to remodeling of nuc-1, which
is positioned immediately downstream of the transcrip-
tion start site. The remodeling appears to be specific for
nuc-1 [1], suggesting involvement of Tat in this process.
However, the mechanisms responsible for this remode-
ling and possible activating effect on transcription
remained elusive.
Integrase-interacting protein 1 (Ini1) was identified as an
HIV IN-interacting factor in a two-hybrid screening [2].
The fact that Ini1, also known as SNF5, is the core sub-unit
of the ATP-dependent chromatin remodeling complex
SWI/SNF, which regulates expression of numerous
eukaryotic genes by altering DNA-histone interactions [3-
5], raised the possibility that Ini1 may contribute to pref-
erential selection of transcriptionally active genes as inte-
gration sites of HIV-1 [6]. This notion was consistent with
the finding that Ini1 stimulated IN activity in vitro [2] and
was recruited from the nucleus to incoming pre-integra-
tion complexes (PICs) of HIV-1 [7]. One proposed model
postulated that SNF5/Ini1 could target PICs to regions of
the genome that are enriched for the SWI/SNF complex
[8].
Two new reports published in this issue of Retrovirology,
as well as several papers in other journals [9-11], chal-
lenge the older findings and suggest a new role for SWI/
SNF in HIV replication. The study by Trono and col-
leagues [12] was designed to investigate the potential role
of Ini1 in HIV-1 integration. Inactivation of Ini1 using
RNA interference did not reduce the transduction effi-
ciency of the VSV-G-pseudotyped HIV-1-based vector sys-
tem, arguing against Ini1 involvement in HIV integration.
This conclusion was supported by effective transduction
of Ini1-deficient cells derived from a malignant rhabdoid
tumor by an HIV-based vector, a result corroborating pre-
vious findings [13]. Using a similar approach, Emiliani
and colleagues [9] observed that silencing of SNF5/Ini1
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resulted in an increase in the formation of 2-LTR circle
and integrated forms of HIV-1 DNA, leading to increased
transduction efficiency and HIV-1 replication. This result
suggests that SNF5/Ini1 may participate in an anti-viral
cellular response. The reason Ariumi and co-authors [12]
did not observe increased transduction efficiency in cells
where Ini1 had been silenced may be due to the use of
VSV-G-pseudotyped constructs in their experiments. Such
constructs enter target cells via endocytosis rather than
fusion with the plasma membrane, thus limiting exposure
of their PICs to cytosolic Ini1.
Surprisingly, Ariumi et al. also reported that HIV-1 repli-
cation in Ini1 knockdown cells was significantly reduced
[12]. They found that Ini1 synergizes with Tat to stimulate
transcription from HIV LTR. Moreover, Ini1 could be co-
immunoprecipitated with Tat, and both Rpt1 and Rpt2,
two direct imperfect repeats required for the formation of
a functional SWI/SNF complex, participated in co-activa-
tion of Tat-mediated HIV-1 transcription. The activation
of Tat-mediated transcription by Ini1, although not
observed by Maroun et al. [9], corroborates results of
Mahmoudi et al. who reported that Ini1, p300 acetyltrans-
ferase and Tat cooperate to activate the HIV promoter
[11]. Acetyltransferase activity of p300 was crucial for this
cooperative effect, as well as the Tat lysines 50 and 51,
which are the targets of acetylation by p300 [14-16]. Inter-
estingly, Tat acetylation on lysines 50 and 51 was found
necessary for interaction with BRG1 [11], a catalytic subu-
nit of SWI/SNF complexes (unfortunately, the role of Tat
acetylation in its interaction with Ini1 has not been
reported). On the other hand, acetylation on lysine 50
prevented interaction of Tat with BRM [10], another DNA-
dependent ATPase of SWI/SNF complexes closely related
to BRG1 [17]. Therefore, it appears that Tat can recruit dif-
ferent SWI/SNF complex subunits to the HIV-1 promoter
in an acetylation-regulated fashion, resulting in a dra-
matic amplification of the Tat activity.
How does the SWI/SNF complex stimulate Tat activity? A
hint to the possible mechanism of this effect was provided
by Agbottah et al. [18]. Consistent with results reported by
Mahmoudi et al. [11], they found that Tat acetylated on
lysines 50 and 51 interacts with BRG1 and both associate
with the activated HIV-1 promoter. Using chromatin
immunoprecipitation assay, Agbottah and co-authors
demonstrated that both Tat and BRG1 can localize to the
site that, in an unactivated HIV promoter, is occupied by
nuc-1 [1]. Consistently, the nuc-1-binding site on HIV
LTR became highly susceptible to digestion by restriction
enzyme Afl II when BRG1 and acetylated Tat were added
to the in vitro transcription reaction performed with chro-
matinized HIV promoter. Neither Tat not BRG1 alone
produced this effect, suggesting that BRG1 may remodel
nuc-1 in a Tat-dependent fashion.
Therefore, the following model can be proposed (Fig. 1).
Following initiation of transcription from the HIV pro-
moter, Tat binds to newly synthesized TAR RNA and
recruits several factors, including acetyltransferase p300
and, via interaction with Ini1 and BRM, the SWI/SNF
complex. The latter initiates remodeling of nuc-1. In the
meantime, acetylation of Tat on lysine 50 by p300 leads
to dissociation of Tat from TAR and creates a binding site
for another acetyltransferase, pCAF. Acetylated Tat recruits
another SWI/SNF complex, this time via Ini1 and BRG1
subunits, which complete remodeling of nuc-1 and allow
elongation of transcription.
Several issues remain to be resolved. Both BRM and BRG1
can associate with Tat, and acetylation on lysine 50 was
found to promote Tat binding to BRG1 but inhibit bind-
ing to BRM. Tat transcriptional activity is regulated by
acetylation, with acetylation at Lys 28 by pCAF promoting
Tat association with pTEFb complex, which phosphor-
A model depicting mechanisms of Nuc-1 remodeling during  HIV-1 transcription Figure 1
A model depicting mechanisms of Nuc-1 remodeling 
during HIV-1 transcription. +1 denotes the transcription 
start site in the HIV-1 LTR. Basal HIV promoter shows an 
elongation defect due to deficient loading of the transcrip-
tional elongation complex pTEFb. Tat binding to the TAR 
stem-loop in the nascent viral RNA recruits pTEFb, which 
phosphorylates the C-terminal domain of RNA pol II and 
increases transcriptional elongation. Via interaction with the 
BRM, a catalytic subunit of SWI/SNF complexes, and a core 
subunit Ini1/SNF5, Tat also recruits the SWI/SNF complex, 
which initiates remodeling of nuc-1. Subsequent acetylation 
of the Tat lysine 50 by p300 results in Tat dissociation from 
TAR, but creates the binding sites for another SWI/SNF cata-
lytic subunit, BRG1. The SWI/SNF complex recruited by the 
Tat acetylated on lysine 50 (which may be different from the 
one recruited by the TAR-bound Tat) completes remodeling 
of nuc-1 and allows the efficient elongation of transcription. 
See text for details.
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ylates the C-terminal domain of RNA polymerase II and
stimulates elongation of transcription, and acetylation at
Lys 50 by p300 leading to the dissociation of Tat from TAR
RNA [15]. Therefore, TAR-bound Tat may recruit BRM-
containing SWI/SNF, whereas BRG1-containing SWI/SNF
complex may be recruited following Tat acetylation by
p300. Do BRM- and BRG1-containing SWI/SNF com-
plexes perform different functions at the HIV LTR? Two
subclasses of SWI/SNF complexes have been described in
eukaryotes: SWI/SNF-α/BAF associated with BRG1 or
BRM, and SWI/SNF-β/pBAF associated with BRG1 only
[17]. The activities of these two types of SWI/SNF com-
plexes differ, so a better characterization of LTR-bound
SWI/SNF complexes would be necessary to determine
their role in HIV transcription. Another remaining ques-
tion is whether chromatin remodeling by SWI/SNF
requires active transcription or just transcription initia-
tion. Agbottah et al. reported that α-amanitin, which spe-
cifically blocks Pol II-dependent transcription, eliminated
the nuc-1 remodeling by Tat and BRG1 [18]. This finding
is in direct conflict with previously reported results that
remodeling of nuc-1 is insensitive to α-amanitin [1].
Another controversy awaiting its resolution concerns
activities of Ini1, which appears to inhibit a pre-integra-
tion step of HIV replication [9] but stimulates transcrip-
tion of the integrated provirus [11,18]. It will be
important also to determine the role of pCAF in nuc-1
remodeling. Finally, the role of Ini1 associated with the
HIV pre-integration complex remains unclear. Sniffing of
SWI/SNF functions in HIV transcription has just begun
and many exciting findings can be expected in the near
future.
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